Vascular endothelial growth factor promotes transdifferentiation of astrocytes into neurons via activation of the MAPK/Erk‐Pax6 signal pathway DOI Creative Commons
Yu Lei, Xiaohong Chen, Jialin Mo

и другие.

Glia, Год журнала: 2023, Номер 71(7), С. 1648 - 1666

Опубликована: Март 24, 2023

Abstract Reactive astrocytes can be transformed into new neurons. Vascular endothelial growth factor (VEGF) promotes the transformation of reactive neurons in ischemic brain. Therefore, this study, molecular mechanism VEGF's effect on ischemia/hypoxia‐induced astrocyte to neuron was investigated models rat middle cerebral artery occlusion (MCAO) and culture with oxygen glucose deprivation (OGD). We found that VEGF enhanced ischemia‐induced Pax6, a neurogenic fate determinant, expression Erk phosphorylation reduced infarct volume brain at 3 days after MCAO, which effects could blocked by administration U0126, MAPK/Erk inhibitor. In cultured astrocytes, also OGD‐induced Pax6 expression, but not wortmannin, PI3K/Akt inhibitor, or SB203580, MAPK/p38 suggesting via activation pathway. OGD induced increase miR365 inhibited expression. However, agonists VEGF‐enhanced hypoxic did block phosphorylation. further promoted astrocyte‐converted neuron. Interestingly, both U0126 RNAi significantly enhancement astrocytes‐to‐neurons transformation, as indicated Dcx MAP2 immunopositive signals astrocytes. Moreover, those become mature functional. concluded astrocytic neurogenesis MAPK/Erk‐miR‐365‐Pax6 signal axis. The results play important roles reconstruction neurovascular units stroke.

Язык: Английский

Celastrol targeting Nedd4 reduces Nrf2-mediated oxidative stress in astrocytes after ischemic stroke DOI Creative Commons
Zexuan Hong, Jun Cao, Dandan Liu

и другие.

Journal of Pharmaceutical Analysis, Год журнала: 2023, Номер 13(2), С. 156 - 169

Опубликована: Янв. 7, 2023

Stroke is the second leading cause of death worldwide, and oxidative stress plays a crucial role. Celastrol exhibits strong antioxidant properties in several diseases; however, whether it can affect oxidation cerebral ischemic-reperfusion injury (CIRI) remains unclear. This study aimed to determine celastrol could reduce damage during CIRI elucidate underlying mechanisms. Here, we found that attenuated by upregulating nuclear factor E2-related 2 (Nrf2). Using alkynyl-tagged liquid chromatography-tandem mass spectrometry, showed directly bound neuronally expressed developmentally downregulated 4 (Nedd4) then released Nrf2 from Nedd4 astrocytes. promoted degradation through K48-linked ubiquitination thus contributed astrocytic reactive oxygen species production CIRI, which was significantly blocked celastrol. Furthermore, inhibiting astrocyte activation, effectively rescued neurons axon apoptosis. Our uncovered as direct target celastrol, exerts an antioxidative effect on astrocytes interaction between reducing CIRI.

Язык: Английский

Процитировано

38

The initiator of neuroexcitotoxicity and ferroptosis in ischemic stroke: Glutamate accumulation DOI Creative Commons
Genhao Fan, Menglin Liu,

Jia Liu

и другие.

Frontiers in Molecular Neuroscience, Год журнала: 2023, Номер 16

Опубликована: Март 23, 2023

Glutamate plays an important role in excitotoxicity and ferroptosis. Excitotoxicity occurs through over-stimulation of glutamate receptors, specifically NMDAR, while the non-receptor-mediated pathway, high concentrations reduce cystine uptake by inhibiting System Xc-, leading to intracellular glutathione depletion resulting ROS accumulation, which contributes increased lipid peroxidation, mitochondrial damage, ultimately Oxidative stress appears crosstalk between ferroptosis, it is essential maintain homeostasis inhibit oxidative responses vivo . As researchers work develop natural compounds further investigate complex mechanisms regulatory functions ferroptosis excitotoxicity, new avenues will be available for effective treatment ischaemic stroke. Therefore, this paper provides a review molecular glutamate-mediated

Язык: Английский

Процитировано

30

15, 16-Dihydrotanshinone I protects against ischemic stroke by inhibiting ferroptosis via the activation of nuclear factor erythroid 2-related factor 2 DOI
Chuanhong Wu, Feipeng Duan, Ruocong Yang

и другие.

Phytomedicine, Год журнала: 2023, Номер 114, С. 154790 - 154790

Опубликована: Март 30, 2023

Язык: Английский

Процитировано

25

nNOS and Neurological, Neuropsychiatric Disorders: A 20-Year Story DOI Open Access
Li‐Juan Zhu, Fei Li, Dong‐Ya Zhu

и другие.

Neuroscience Bulletin, Год журнала: 2023, Номер 39(9), С. 1439 - 1453

Опубликована: Апрель 19, 2023

Язык: Английский

Процитировано

25

Acute Spontaneous Lobar Cerebral Hemorrhages Present a Different Clinical Profile and a More Severe Early Prognosis than Deep Subcortical Intracerebral Hemorrhages—A Hospital-Based Stroke Registry Study DOI Creative Commons

Joana Maria Flaquer-Pérez de Mendiola,

Adrià Arboix, Luis Garcı́a-Eroles

и другие.

Biomedicines, Год журнала: 2023, Номер 11(1), С. 223 - 223

Опубликована: Янв. 16, 2023

Acute spontaneous intracerebral hemorrhage (ICH) is the most severe stroke subtype, with a high risk of death, dependence, and dementia. Knowledge about clinical profile early outcomes ICH patients lobar versus deep subcortical brain topography remains limited. In this study, we investigated effects on demographics, cerebrovascular factors, characteristics, in sample 298 consecutive acute (165 133 hemorrhagic stroke) available single-center-based registry over 24 years. The multiple logistic regression analysis shows that variables independently associated were seizures (OR 6.81, CI 95% 1.27−5.15), chronic liver disease 4.55, 1.03−20.15), hemianopia 2.55, 1.26−5.15), headaches 1.90, IC 1.06−3.41), alcohol abuse (>80 gr/day) 0−10, 0.02−0,53), hypertension 0,41, 0.23−0−70), sensory deficit 0.43, 0.25−0.75), limb weakness (OR: 0.47, 0.24−0.93). in-hospital mortality was 26.7% for 16.5% ICH. study confirmed spectrum, prognosis, depend site bleeding, more prognosis hemorrhage.

Язык: Английский

Процитировано

24

METTL3 regulates TFRC ubiquitination and ferroptosis through stabilizing NEDD4L mRNA to impact stroke DOI Creative Commons
Wenjie Su, Xiang Yu, Shan Wang

и другие.

Cell Biology and Toxicology, Год журнала: 2024, Номер 40(1)

Опубликована: Фев. 2, 2024

Abstract Background Stroke is a major medical problem, and novel therapeutic targets are urgently needed. This study investigates the protective role potential mechanisms of N6-methyladenosine (m6A) RNA methyltransferase METTL3 against cerebral injury resulting from insufficient blood flow. Methods In this study, we constructed mouse MCAO models HT-22 cell OGD/R to mimic ischemic stroke-induced brain neuronal damage. We generated NEDD4L knockout overexpression validated effects using infarct volume, edema, neurologic scoring. performed qRT-PCR, western blotting, co-immunoprecipitation assess influence on ferroptosis markers TFRC expression. verified effect ubiquitination by detecting half-life ubiquitination. Finally, impact mRNA stability outcomes in both vitro vivo experimental models. Result find expression downregulated Overexpressing inhibits iron carrier protein upregulating E3 ubiquitin ligase NEDD4L, thereby alleviating oxidative damage protect injury. Mechanistic studies show can methylate stabilize mRNA, enhancing As downstream effector, ubiquitinates degrades TFRC, reducing accumulation ferroptosis. Conclusion summary, uncover METTL3-NEDD4L-TFRC axis critical for inhibiting post-ischemic Enhancing pathway may serve as an effective strategy stroke therapy. lays theoretical foundation developing m6A-related therapies

Язык: Английский

Процитировано

15

SIRT5 Regulates Ferroptosis through the Nrf2/HO-1 Signaling Axis to Participate in Ischemia-Reperfusion Injury in Ischemic Stroke DOI
Jian Li, Wei Gao,

Zhaoming Song

и другие.

Neurochemical Research, Год журнала: 2024, Номер 49(4), С. 998 - 1007

Опубликована: Янв. 3, 2024

Язык: Английский

Процитировано

13

Psychedelics for acquired brain injury: a review of molecular mechanisms and therapeutic potential DOI
Josh Allen, Shannon Dames, Claire J. Foldi

и другие.

Molecular Psychiatry, Год журнала: 2024, Номер 29(3), С. 671 - 685

Опубликована: Янв. 4, 2024

Язык: Английский

Процитировано

13

Novel Multi-Antioxidant Approach for Ischemic Stroke Therapy Targeting the Role of Oxidative Stress DOI Creative Commons
Camilo Briones-Valdivieso,

Felipe Briones,

Sofía Orellana-Urzúa

и другие.

Biomedicines, Год журнала: 2024, Номер 12(3), С. 501 - 501

Опубликована: Фев. 23, 2024

Stroke is a major contributor to global mortality and disability. While reperfusion essential for preventing neuronal death in the penumbra, it also triggers cerebral ischemia-reperfusion injury, paradoxical injury primarily caused by oxidative stress, inflammation, blood–brain barrier disruption. An burst inflicts marked cellular damage, ranging from alterations mitochondrial function lipid peroxidation activation of intricate signalling pathways that can even lead cell death. Thus, given pivotal role stress mechanisms reinforcement antioxidant defence system has been proposed as protective approach. Although this strategy proven be successful experimental models, its translation into clinical practice yielded inconsistent results. However, should considered availability numerous molecules with wide range chemical properties affect extent injury; several groups molecules, including polyphenols, carotenoids, vitamins, among other compounds, mitigate damage intervening multiple at various stages. Multiple trials have previously conducted evaluate these using melatonin, acetyl-L-carnitine, chrysanthemum extract, edaravone dexborneol, saffron, coenzyme Q10, oleoylethanolamide, treatments. Therefore, multi-antioxidant therapy emerges promising novel therapeutic option due potential synergistic effect provided simultaneous roles individual compounds.

Язык: Английский

Процитировано

13

Melatonin alleviates ischemic stroke by inhibiting ferroptosis through the CYP1B1/ACSL4 pathway DOI
Yu Sun, Haiyan Jin, Jia He

и другие.

Environmental Toxicology, Год журнала: 2024, Номер 39(5), С. 2623 - 2633

Опубликована: Янв. 11, 2024

Abstract This study utilized middle cerebral artery occlusion (MCAO) mouse models and HT‐22 cell oxygen glucose deprivation/reoxygenation (OGD/R) to investigate the therapeutic effects of melatonin on ischemic brain injury. In experiments, MCAO mice were treated with 5 10 mg/kg doses melatonin, H‐T22 cells underwent OGD/R treatment administered different concentrations melatonin. The results showed that significantly reduced area, neural damage, edema, neuronal apoptosis in mice. model, also improved proliferation ability, apoptosis, ROS production. Further mechanistic studies found exerts protective by inhibiting ferroptosis, an iron‐dependent form regulated death, through regulation ACSL4/CYP1B1 pathway. mice, decreased lipid peroxidation, production, ACSL4 protein expression. Overexpression CYP1B1 increased ubiquitination degradation, thereby increasing tolerance reducing levels, decreasing knockdown obtained opposite results. metabolite 20‐HETE induces expression E3 ubiquitin ligase FBXO10 activating PKC signaling, which promotes degradation. inhibition reversed summary, this demonstrates protects from injury ferroptosis pathway, providing evidence for new targets

Язык: Английский

Процитировано

10